Related Experiment Video
Updated: May 18, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Treatment outcomes and associated factors among persons with pulmonary tuberculosis in Morocco: a systematic review
Omayma Benbrik1,2, Oumaima Bounar3, Imad Chakri3
1Research and Innovation Laboratory in Health Science, Faculty of Medicine and Pharmacy, Ibn Zohr University, Agadir, Morocco. omayma.benbrik@edu.uiz.ac.ma.
Background:
Tuberculosis (TB) remains a major public health challenge. Treatment success rate (TSR) is a key indicator for TB control, yet national level evidence on treatment outcomes in Morocco is fragmented. This systematic review and meta-analysis aimed to estimate pooled TB treatment outcomes and summarize factors influencing success and unsuccessful outcomes among persons with pulmonary tuberculosis (PTB).
Methods:
We systematically searched PubMed, ScienceDirect, and Web of Science for studies published up to January 2025. The research question was structured using the PICO framework: participants (adults with PTB), intervention (anti-tuberculosis treatment), and outcomes (TB treatment outcomes). Eligible studies were conducted in Morocco, published in English or French, and reported TB treatment outcomes; non-original articles, studies without outcome data, and those outside Morocco were excluded. Two reviewers independently performed study selection, data extraction, and quality assessment. Meta-analysis was conducted in R software, calculating pooled TSR, unsuccessful treatment outcomes, failure, loss to follow-up, and death rates using a random-effects model. Subgroup analyses were performed by drug-susceptibility status and treatment history. Heterogeneity was assessed using the I² statistic, and risk of bias was evaluated using Joanna Briggs Institute Critical Appraisal Checklists of prevalence and case control studies.
Results:
Thirty-three studies were included. Pooled estimates showed a TSR of 79.00% (95%CI:72.85-84.07, I²=99%), defined as the proportion of persons with tuberculosis who were cured or completed treatment among all treated cases. The pooled proportion of unsuccessful treatment outcomes was 10.03% (95%CI:7.17-13.85,I²=99%), with separate estimates for treatment failure (1.86%, 95%CI:1.08-3.19), loss to follow-up (5.49%,95%CI:3.47-8.59) and death rate (2.00%, 95%CI:1.20-3.30). Subgroup analysis showed lower TSR and higher unsuccessful outcomes among drug-resistant and retreatment cases. Associated factors for higher TSR included younger age, new and smear-negative cases, and enrollment in integrative health programs. Factors linked to unsuccessful outcomes included older age, male gender, rural residence, and smoking.
Conclusion:
TSR among persons with TB in Morocco remains below the WHO target (≥ 90%), with higher unsuccessful outcomes observed among drug-resistant and retreatment cases. Considerable variability across studies highlights the need for targeted interventions. These findings may inform program strategies to improve TB treatment outcomes.
Trial Registration:
Clinical trial number: Not applicable.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Therapeutic Drug Monitoring: Affecting Factors

